Doxycycline vs Cefixime: Clinical Selection Guide
Doxycycline and cefixime serve fundamentally different clinical roles and are not interchangeable—doxycycline is a tetracycline antibiotic primarily used for atypical respiratory pathogens, sexually transmitted infections, and tick-borne diseases, while cefixime is a third-generation oral cephalosporin reserved mainly for gonorrhea (as second-line) and select urinary tract infections.
Antimicrobial Spectrum and Primary Indications
Doxycycline
- Covers atypical respiratory pathogens (Mycoplasma, Chlamydia pneumoniae) that cefixime cannot treat 1
- First-line for Chlamydia trachomatis at 100 mg twice daily for 7 days, which commonly co-infects with gonorrhea 2, 3
- Essential for Lyme disease treatment (early localized and disseminated disease) at 100 mg twice daily 4
- Covers tick-borne illnesses including anaplasmosis and ehrlichiosis 4
- Effective against MRSA in skin/soft tissue infections (not covered by cefixime) 5
- Contraindicated in pregnancy, lactation, and children <8 years due to tooth discoloration 4, 6
Cefixime
- Limited to specific Gram-negative coverage: excellent against Enterobacteriaceae and H. influenzae, but poor Gram-positive activity 1, 7
- Second-line for gonorrhea only: 400 mg orally plus azithromycin 1 g when ceftriaxone unavailable, with mandatory test-of-cure at 1 week 8
- Not recommended for pharyngeal gonorrhea due to 5.8% failure rate versus 1.8% for ceftriaxone 8
- Achieves lower bactericidal levels than ceftriaxone (97.1-97.4% cure rate vs 98.9-99.1%) 8
- Recent evidence shows treatment failure: cefixime 800 mg plus doxycycline failed noninferiority testing for pharyngeal gonorrhea (86% success vs 100% for ceftriaxone-azithromycin) 9
- Urinary tract infections: effective for uncomplicated UTI due to high urinary concentrations, comparable to co-trimoxazole or amoxicillin 7, 10
- No activity against Pseudomonas, Staphylococcus aureus, or atypical pathogens 7
Clinical Decision Algorithm
For Respiratory Tract Infections
- Acute bacterial rhinosinusitis with recent antibiotic use or moderate disease: Use amoxicillin-clavulanate 90 mg/6.4 mg/kg per day, NOT cefixime or doxycycline as monotherapy 1
- Atypical pneumonia suspected (Mycoplasma, Chlamydia): Doxycycline 100 mg twice daily 1
- Streptococcal pharyngitis: Neither agent is appropriate—use penicillin V or amoxicillin 6
- Acute bronchitis: Cefixime 400 mg once daily showed equivalent efficacy to cefuroxime but caused significantly more diarrhea (15% vs 5%, p=0.001) 11
For Sexually Transmitted Infections
- Uncomplicated gonorrhea: Ceftriaxone 250 mg IM plus azithromycin 1 g orally is first-line; cefixime 400 mg plus azithromycin 1 g is alternative only when ceftriaxone unavailable 2, 3, 8
- Chlamydia co-infection (present in majority of gonorrhea cases): Doxycycline 100 mg twice daily for 7 days is preferred over single-dose azithromycin for chlamydial coverage 2, 3
- Never use cefixime as monotherapy for gonorrhea—must combine with azithromycin 8
For Urinary Tract Infections
- Uncomplicated UTI: Cefixime 200 mg twice daily (preferred over 400 mg once daily due to less GI upset) is comparable to amoxicillin or co-trimoxazole 7, 10
- Complicated UTI: Cefixime only if sensitivity confirmed; requires testing due to resistant Gram-positive and non-fermenting organisms 10
- Doxycycline is not first-line for UTI treatment 1
Patient-Specific Factors
Renal Impairment
- Cefixime requires dose adjustment as 20% is renally excreted as active drug 7
- Doxycycline does not require adjustment and is safer in renal failure 4
Penicillin Allergy
- Cefixime has negligible cross-reactivity with penicillin as a third-generation cephalosporin 8
- Avoid cephalosporins in Type I hypersensitivity (anaphylaxis) to penicillin 1, 12
- Doxycycline is safe alternative for penicillin-allergic patients in appropriate indications 1, 4
Pregnancy and Pediatrics
- Doxycycline is contraindicated in pregnancy, lactation, and children ≤8 years 4, 6
- Cefixime is safe in pregnancy and children when indicated 1, 7
Critical Pitfalls to Avoid
- Never confuse ceftriaxone with cefixime—ceftriaxone has no oral formulation and provides superior bactericidal levels 8
- Do not use cefixime for pharyngeal gonorrhea—documented high failure rates 8, 9
- Cefixime has no anti-pseudomonal activity—never use empirically in febrile neutropenia 8
- Cefixime lacks activity against S. pneumoniae and MRSA—inappropriate for most respiratory infections requiring Gram-positive coverage 1, 7
- Doxycycline cannot treat gonorrhea alone—only covers co-existing chlamydia 2, 3
- Higher GI adverse effects with once-daily cefixime dosing—use 200 mg twice daily instead of 400 mg once daily 10, 11